DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Firms / B•• V••••••• M••••••••• C••••••• L••
B•• V••••••• M••••••••• C••••••• L••
Institutional venture firmShreveport, LAc•••••••••.comSEC venture capital fund adviserfundraising evidence
Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.
venture manager, reported GAV $94M across 6 vehicles
Importance
18
moderate
Active deployment
60
high
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
18
moderate
Identity and regulatory footprint
- Headquarters
- Shreveport, LAadviserinfo.sec.gov
- Office address
- 2031 KINGS HIGHWAY, Shreveport, LA, 71103adviserinfo.sec.gov
- Business phone
- (318) 746-8430adviserinfo.sec.gov
- Website
- c•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 25, 2026
- Private funds reported
- 5 (5 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $148Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- (318) 746-8430adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- ai, biotech, space
- Stages
- series a, early
- Geography
- germany, israel, texas
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
6 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| C••••• F•••• F••• I•• L• | Fund | 2025 form d first sale | Fundraising | unknown | unknown | $22.6M of $250M | May 22, 2026 |
| C••••• F•••• F•••• L• | Fund | 2019 form d first sale | Mature | $43.4M Mar 29, 2024 | 19 | $49.7M of $75.0M | Dec 24, 2019 |
| T•••••••• V•••••••• L••• | Fund | unknown | Unknown | $23.2M Mar 29, 2024 | 5 | unknown | unknown |
| T••••••• V•••••••• L••• | Fund | unknown | Unknown | $12.3M Mar 29, 2024 | 6 | unknown | unknown |
| T•••••••• V••••••• I•••• L••• | Feeder or parallel | unknown | Unknown | $8.6M Mar 29, 2024 | 5 | unknown | unknown |
| T•••••••• V••••••• I•• L••• | Fund | unknown | Unknown | $6.5M Mar 29, 2024 | 7 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
1 current, 0 departed
R••• P•••• B••••••
Managing partnerManaging Member · since Jan 1, 2007
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
6 dated events
- Apr 24, 2020C••••• F•••• F•••• L• first reported on Form ADV by B•• V••••••• M••••••••• C••••••• L•• (Venture Capital Fund), GAV $49,700,000Fund first reported on Form ADVFundsFactC••••• F•••• F•••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 19, 2017BVM Capital, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 19, 2017T•••••••• V•••••••• L••• first reported on Form ADV by BVM Capital, LLC (Venture Capital Fund), GAV $44,120,652Fund first reported on Form ADVFundsFactT•••••••• V•••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 19, 2017T•••••••• V••••••• I•• L••• first reported on Form ADV by BVM Capital, LLC (Venture Capital Fund), GAV $5,043,105Fund first reported on Form ADVFundsFactT•••••••• V••••••• I•• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 19, 2017T•••••••• V••••••• I•••• L••• first reported on Form ADV by BVM Capital, LLC (Venture Capital Fund), GAV $9,763,197Fund first reported on Form ADVFundsFactT•••••••• V••••••• I•••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 19, 2017T••••••• V•••••••• L••• first reported on Form ADV by BVM Capital, LLC (Venture Capital Fund), GAV $1,918,000Fund first reported on Form ADVFundsFactT••••••• V•••••••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $94M across 6 vehicles
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $94M across 5 vehicles
Evidence
52 observations from 3 sources